¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"inhibitory hormone"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 1 ÆäÀÌÁö: 2
¿µ¹® luteinizing hormone(LH) ÇÑ±Û È²Ã¼Çü¼ºÈ£¸£¸ó
¼³¸í   
  ¿©¼ºÀÇ ¿ù°æÀº Á¤ÇØÁø ¼ø¼­¿¡ ÀÇÇØ ÀϾ°Ô µÈ´Ù. ¸ÕÀú ³­Æ÷ÀÚ±ØÈ£¸£¸óÀÌ ³ú¿¡¼­ ºÐºñµÇ¾î ¿©¼ºÀÇ ³­¼Ò¸¦ ÀÚ±ØÇϰԠµÇ¸é ³­Æ÷°¡ Àڱع޾Ơ³­Æ÷È£¸£¸ó(¿¡½ºÆ®·ÎÁ¨)À» ºÐºñÇϰԠµÇ°í À̰ÍÀº ´Ù½Ã µÇ¸ÔÀ̱⠸ÞÄ¿´ÏÁò ÀÇÇØ ³ú¿¡ ÀÛ¿ëÀ» ÇÏ¿© È²Ã¼È­È£¸£¸óÀÌ ³ú¿¡¼­ ºÐºñµÇ°í À̰ÍÀÌ À̸¥¹Ù ÀýÁ¤¿¡ À̸£·¶À» ¶§, ³­Æ÷¿¡¼­ ¹è¶õÀÌ ÀϾ°Ô µÈ´Ù. ÀÌÈÄ ³­Æ÷´Â È²Ã¼·Î º¯ÇϰԠµÇ¸ç, ¹è¶õµÈ ³­ÀÚ°¡ ¼öÁ¤µÇÁö ¾Æ´ÏÇϸé, È²Ã¼´Â È²Ã¼È£¸£¸ó(ÇÁ·Î°Ô½ºÅ×·Ð)À» ºÐºñÇÑ µÚ ÅðÈ­µÇ°í °ð À̾ù°æÀÌ ÀϾ°Ô µÈ´Ù. ÀÌ ÀÏÀº Á¤»óÀûÀΠ´ëºÎºÐÀÇ ¿©¼º¿¡¼­ 28ÀÏÀ» ÁÖ±â·Î ÀϾ¸ç, ´ë°³ È²Ã¼È­È£¸£¸ó ÀýÁ¤ ÀÌÈÄ ¸¶Áö¸·Àº 14ÀϷΠÀÏÁ¤ÇÏ´Ù°í ÇÑ´Ù.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • macrophage migration inhibitory factor
    Å«Æ÷½Ä¼¼Æ÷À̵¿ÀúÁöÀÎÀÚ, ´ë½Ä¼¼Æ÷À̵¿ÀúÁöÀÎÀÚ
  • prolactin inhibitory factor
    ÇÁ·Î¶ôƾºÐºñ¾ïÁ¦ÀÎÀÚ
  • peripheral inhibitory field
    ¸»ÃʾïÁ¦¿µ¿ª
  • reticular inhibitory area
    ±×¹°Ã¼¾ïÁ¦ºÎÀ§
  • virus inhibitory factor
    ¹ÙÀÌ·¯½º¾ïÁ¦ÀÎÀÚ
  • antidiuretic hormone
    Ç×ÀÌ´¢È£¸£¸ó
  • adrenal corticotropic hormone
    ºÎ½Å°ÑÁúÀÚ±ØÈ£¸£¸ó, ºÎ½ÅÇÇÁúÀÚ±ØÈ£¸£¸ó
  • adrenocortical hormone
    ºÎ½Å°ÑÁúÈ£¸£¸ó, ºÎ½ÅÇÇÁúÈ£¸£¸ó
  • adrenocorticotropic hormone
    ºÎ½Å°ÑÁúÀÚ±ØÈ£¸£¸ó, ºÎ½ÅÇÇÁúÀÚ±ØÈ£¸£¸ó
  • adrenomedullary hormone
    ºÎ½Å¼ÓÁúÈ£¸£¸ó, ºÎ½Å¼öÁúÈ£¸£¸ó
  • androgenic hormone
    ³²¼º(È­)È£¸£¸ó
  • corticosteroid hormone
    ÄÚ¸£Æ¼ÄÚ½ºÅ×·ÎÀ̵åÈ£¸£¸ó
  • corticotropin-releasing hormone
    ÄÚ¸£Æ¼ÄÚÆ®·ÎÇɺкñÈ£¸£¸ó
  • diabetogenic hormone
    ´ç´¢º´¹ß»ýÈ£¸£¸ó
  • ectopic hormone
    µý°÷È£¸£¸ó, À̼ҼºÈ£¸£¸ó
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 1 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • syndrome of inappropriate antidiuretic hormone
    Ç×ÀÌ´¢È£¸£¸óºÎÀûÀýºÐºñÁõÈıº
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • prolactin inhibitory factor
    ÇÁ·Î¶ôƾºÐºñ¾ïÁ¦ÀÎÀÚ
  • virus inhibitory factor
    ¹ÙÀÌ·¯½º¾ïÁ¦ÀÎÀÚ
  • inhibitory interneuron
    ¾ïÁ¦»çÀ̽Ű漼Æ÷
  • inhibitory synapse
    ¾ïÁ¦¿¬Á¢
  • inhibitory transmitter
    ¾ïÁ¦Àü´Þ¹°
  • inhibitory postsynaptic potential
    ¾ïÁ¦½Ã³ÀÈÄÀüÀ§, ¾ïÁ¦¿¬Á¢ÈÄÀüÀ§
  • adrenal corticotropic hormone
    ºÎ½Å°ÑÁúÀÚ±ØÈ£¸£¸ó
  • adrenocortical hormone
    ºÎ½Å°ÑÁúÈ£¸£¸ó
  • adrenocorticotropic hormone
    ºÎ½Å°ÑÁúÀÚ±ØÈ£¸£¸ó
  • adrenomedullary hormone
    ºÎ½Å¼ÓÁúÈ£¸£¸ó
  • androgenic hormone
    ³²¼ºÈ£¸£¸ó
  • antidiuretic hormone
    Ç×ÀÌ´¢È£¸£¸ó
  • hormone bombardment
    È£¸£¸óÃæ°Ý¿ä¹ý
  • corticosteroid hormone
    ÄÚ¸£Æ¼ÄÚ½ºÅ×·ÎÀ̵åÈ£¸£¸ó
  • corticotropin-releasing hormone
    ÄÚ¸£Æ¼ÄÚÆ®·ÎÇɺкñÈ£¸£¸ó
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • inhibitory effect
    ¾ïÁ¦È¿°ú.
  • inhibitory enzyme
    ÀúÇØÈ¿¼Ò.
  • inhibitory junctional potential
    ¾ïÁ¦¼º Á¢ÇÕºÎÀü¾Ð(ïÈùêݬï³äâ).
  • inhibitory nerve
    ¾ïÁ¦½Å°æ(åäð¤ãêÌè).
  • inhibitory nerve
    ¾ïÁ¦½Å°æ.
  • inhibitory postsynaptic potential
    ¾ïÁ¦¼º ½Ã³³½ºÈÄ Àü¾Ð
  • inhibitory postsynaptic potential
    ¾ïÁ¦¼º ½Ã³³½ºÈÄÀü¾Ð.
  • inhibitory postsynaptic potential = IPSP
    ¾ïÁ¦¼º ½Ã³³½ºÈÄÀü¾Ð.
  • inhibitory synapse
    ¾ïÁ¦¼º(åäð¤àõ) ½Ã³³½º.
  • inhibitory synapse
    ¾ïÁ¦¼º ½Ã³³½º.
  • inhibitory transmitter
    ¾ïÁ¦¼º Àü´Þ¹°Áú.
  • inhibitory zone
    ¾ïÁ¦¹üÀ§(åäð¤ÛôêÌ).
  • prolactin-inhibitory factor(PIF)
    ÇÁ·Î¶ôƾ ºÐºñ ¾ïÁ¦ ÀÎÀÚ
  • ACTH=£¾adrenocorticotropic hormone
    ºÎ½ÅÇÇÁúÀÚ±ØÈ£¸£¸ó
  • ADH =£¾antidiuretic hormone
    Ç×ÀÌ´¢È£¸£¸ó
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • inhibitory nerve
    ¾ïÁ¦½Å°æ(åäð¤ãêÌè).
  • inhibitory postsynaptic potential
    ¾ïÁ¦¼º ½Ã³³½ºÈÄÀü¾Ð.
  • inhibitory postsynaptic potential
    ¾ïÁ¦¼º ½Ã³³½ºÈÄ Àü¾Ð
  • inhibitory postsynaptic potential = IPSP
    ¾ïÁ¦¼º ½Ã³³½ºÈÄÀü¾Ð.
  • inhibitory synapse
    ¾ïÁ¦¼º ½Ã³³½º.
  • inhibitory synapse
    ¾ïÁ¦¼º(åäð¤àõ) ½Ã³³½º.
  • inhibitory transmitter
    ¾ïÁ¦¼º Àü´Þ¹°Áú.
  • inhibitory zone
    ¾ïÁ¦¹üÀ§(åäð¤ÛôêÌ).
  • lymphocyte inhibitory factor (LIF)
    ¸²ÇÁ±¸¾ïÁ¦ÀÎÀÚ
  • macrophage migration inhibitory factor
    ´ë½Ä¼¼Æ÷ À¯ÁÖÀúÁöÀÎÀÚ.
  • migration inhibitory factor =MIF
    ´ë½Ä¼¼Æ÷À¯ÁÖÀúÁöÀÎÀÚ(ÓÞãÝá¬øàë´ñËîÁ ò­ì×í­).
  • migratory inhibitory factor
    À̵¿¼º ¾ïÁ¦ÀÎÀÚ
  • minimal inhibitory concentration
    ÃÖÀú¹ßÀ°ÀúÁö³óµµ(õÌî¸Û¡ëÀðæò­ÒØöô).
  • minimum inhibitory concentration
    ÃÖ¼Ò¹ßÀ°ÀúÁö³óµµ(õÌá³Û¡ëÀîÁò­ÒØöô).
  • minimum inhibitory concentration
    ÃÖ¼Ò¾ïÁ¦³óµµ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • thyrotropic hormone releasing hormone
    °©»ó¼±ÀÚ±Ø (ë´×îí©Ð½) È£¸£¸ó À¯¸®(ë´×î)È£¸£¸ó
  • adipokinetic hormone
    Áö¹æµ¿¿ø(ò·Û²ÔÑê¬)È£¸£¸ó
  • adrenal cortical hormone
    ºÎ½ÅÇÇÁú(Üùãìù«òõ)È£¸£¸ó
  • adrenocorticotropic hormone
    ºÎ½ÅÇÇÁúÀÚ±Ø(Üùãìù«òõ í©Ð½)È£¸£¸ó
  • animal hormone
    µ¿¹°(ÔÑÚª)È£¸£¸ó
  • antidiuretic hormone
    Ç×ÀÌ´¢(ù÷××Òã)È£¸£¸ó
  • autocrine hormone
    ÀÚ°¡ºÐºñ (í»Ê«ÝÂÝô) È£¸£¸ó
  • brain hormone
    ³ú(Òà)È£¸£¸ó
  • chemotactic hormone
    È­ÇÐÁÖ¼º(ûùùÊñËàõ) È£¸£¸ó
  • corticotropin releasing hormone
    ÄÚ¸£Æ¼ÄÚÆ®·ÎÇÉ À¯¸®(ë´×î) È£¸£¸ó
  • diabetogenic hormone
    ´ç´¢º´¹ß»ý(ÓØÒãÜ»Û¡ßæ)È£¸£¸ó
  • eclosion hormone
    ¿ìÈ­(éâûù) È£¸£¸ó
  • ectopic hormone syndrome
    À̼Ò(ì¶á¶) È£¸£¸ó ÁõÈıº(ñøý¦ÏØ)
  • emergency hormone
    ÀÀ±Þ(ëëÐá) È£¸£¸ó
  • female sex hormone
    ¿©¼º(Ò³àõ) ¼º(àõ)È£¸£¸ó
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 2
FSH-RH Follicle Stimulating Hormone Releasing Hormone
GHRH Growth Hormone Releasing Hormone
GIH Growth hormone release Inhibiting Hormone
  = Somatostatin
GRH Growth hormone Releasing Hormone
FRH follicle-stimulating hormone-releasing hormone
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 2
hGHRH Human growth-hormone-releasing hormone
LH-RH Luteinising Hormone-Releasing Hormone
LRH Luteinizing Hormone Releasing Hormone
LHRH-A luteinizing hormone releasing hormone agonist
LHRHa leuteinizing hormone-releasing hormone analogue
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • minimum inhibitory dose
    ÃÖ¼Ò ¾ïÁ¦·®
  • peripheral inhibitory field
    ¸»ÃÊ ¾ïÁ¦¾ß
  • presynaptic inhibitory action
    ½Ã³³½ºÀü ¾ïÁ¦ ÀÛ¿ë
  • virus inhibitory factor
    ¹ÙÀÌ·¯½º ¾ïÁ¦ ÀÎÀÚ
  • adrenal corticotropic hormone
    ºÎ½Å ÇÇÁú ÀÚ±Ø È£¸£¸ó
  • adrenocorticotrophic hormone
    ºÎ½Å ÇÇÁú ÀÚ±Ø È£¸£¸ó
    ³úÇϼöü Àü¿±¿¡¼­ ºÐºñµÇ´Â È£¸£¸ó. ºÎ½Å ÇÇÁú¿¡ ÀÛ¿ëÇØ¼­ ¼± ¼¼Æ÷ÀÇ Áõ½Ä, È£¸£¸óÀÇ ÇÕ¼º°ú ºÐºñ¸¦ ÃËÁøÇÑ´Ù. »ç¶÷ÀÇ °æ¿ì, 39°³ÀÇ ¾Æ¹Ì³ë»êÀ¸·Î Çü¼ºµÇ´Â Æú¸® ÆéƼµå·Î È­ÇÐÀûÀ¸·Î´Â ´Ü¹éÁúÀÌ´Ù. »ýü°¡ ½ºÆ®·¹½º¸¦ ¹ÞÀ¸¸é ÁßÃ߽Űæ°è¸¦ ÅëÇØ ÀÌ È£¸£¸ó ºÐºñ°¡ ÃËÁøµÇ¾î ºÎ½Å ÇÇÁú È£¸£¸óÀÌ ´Ù·®À¸·Î °ø±ÞµÈ´Ù. ACTH´Â ¶Ç ÄÚ¸£Æ¼¼Õ µî ºÎ½Å ÇÇÁú È£¸£¸óÀ» ¸Å°³·Î Çϸç, °áÇÕÁ¶Á÷ÀÇ ´ë»ç ÀÌ»óÀ» Á¶Á¤ÇÏ°í ·ù¸ÓƼÁò¼º ¶Ç´Â ·ù¸ÓƼÁò Áúȯ¿¡ È¿°ú°¡ ÀÖ´Ù.
  • adrenocorticotropic hormone
    ºÎ½Å ÇÇÁú ÀÚ±Ø È£¸£¸ó
    ³úÇϼöü Àü¿±¿¡¼­ »ý¼º, ºÐºñµÇ¾î ºÎ½Å ÇÇÁú¿¡ ÀÛ¿ëÇØ¼­ ÄÚÆ¼¼Ö ¹× ÄÚÆ¼ÄÚ½ºÅ×·ÐÀÇ ºÐºñ¸¦ ÃËÁøÇϴ ȣ¸£¸ó. ½ºÆ®·¹½º ½Ã¿¡ ½Ã»óÇϺο¡ ÈïºÐÀÌ ÀϾ Á¤Áß À¶±â¿¡¼­ ºÎ½Å ÇÇÁú ÀÚ±Ø È£¸£¸ó ¹æÃâ ÀÎÀÚ°¡ ¸ÕÀú ºÐºñµÇ¸é À̰ÍÀÌ ³úÇϼöü ¹®¸ÆÀ» ÅëÇØ¼­ ³úÇϼöü Àü¿±¿¡ µµ´ÞÇÏ¿© °Å±â¿¡¼­ ACTHÀÇ »ý¼º ¹× ºÐºñ¸¦ ÃËÁøÇÑ´Ù.
  • adrenomedullary hormone
    ºÎ½Å ¼öÁú È£¸£¸ó
  • antidiuretic hormone
    Ç×ÀÌ´¢ È£¸£¸ó
    ADH-vaso
  • chromatophoriotropic hormone
    Çâ»ö¼Ò º¸À¯ ¼¼Æ÷ È£¸£¸ó
  • cortical hormone
    ÇÇÁú È£¸£¸ó
  • corticosteroid hormone
    ÄÚÆ¼ÄÚ½ºÅ×·ÎÀ̵å È£¸£¸ó
  • female hormone
    ¿©¼º È£¸£¸ó
    ôÃß µ¿¹° ¾ÏÄÆÀÇ ³­¼Ò¿¡¼­ ºÐºñµÇ¾î ¼º±âÀÇ ¹ßÀ°°ú »ý½Ä±â´É Á¶Àý µî¿¡ ÀÛ¿ëÇÏ´Â ¼º È£¸£¸ó. ³­¼Ò È£¸£¸óÀ̶ó°íµµ ÇÑ´Ù. ¿©Æ÷¿¡¼­ ³ª¿À´Â ¿©Æ÷ È£¸£¸ó°ú Ȳü¿¡¼­ ³ª¿À´Â Ȳü È£¸£¸óÀÌ ÀÖ´Ù. ÀÇ¾à ¹æ¸é¿¡¼­ º¸Åë ¿©¼º È£¸£¸óÀ̶ó°í ÇÒ ¶§´Â ¿©Æ÷ È£¸£¸óÀ» ¸»ÇÑ´Ù. ¿©Æ÷ È£¸£¸óÀº ¹ßÁ¤ È£¸£¸óÀ¸·Î ¿©¼º »ý½Ä±âÀÇ ¹ßÀ°À» ÃËÁøÇÏ¿© ¿©¼º´Ù¿òÀ» ÁõÁø½ÃŲ´Ù. Ȳü È£¸£¸óÀº ¹ßÁ¤ È£¸£¸ó¿¡ ±æÇ×ÀûÀ¸·Î ÀÛ¿ëÇÏ¿© ¹ßÁ¤À» ¾ïÁ¦ÇÑ´Ù. À̵é È£¸£¸óÁ¦ÀÇ »ç¿ëÀº ÀÎü¿¡ ÀÌ»óÇÑ ¹ÝÀÀÀ» ÀÏÀ¸Å°´Â ¼ö°¡ ÀÖÀ¸¹Ç·Î ±× »ç¿ëÀº ¹Ýµå½Ã Àü¹® ÀÇ»çÀÇ Áö½Ã¿¡ µû¶ó¾ß ÇÑ´Ù. ¹ßÁ¤ È£¸£¸óÀÇ ÀÛ¿ëÀ» °¡Áø ¹°ÁúÀ» ÃÑÄªÇØ¼­ ¿¡½ºÆ®·Î°Õ
  • follicle stimulating hormone releasing factor
    ³­Æ÷ ÀÚ±Ø È£¸£¸ó ¹æÃâ ÀÎÀÚ
  • follicular hormone
    ¿©Æ÷ È£¸£¸ó
    ôÃßµ¿¹°ÀÇ ³­¼Ò ¾È¿¡ ÀÖ´Â ³­Æ÷¿¡¼­ ºÐºñµÇ´Â ÀÚ¼º È£¸£¸ó. ³­Æ÷ È£¸£¸ó, ¹ßÁ¤ È£¸£¸óÀ̶ó°íµµ ÇÑ´Ù. »ý½Ä±â¸¦ ¹ßÀ°½ÃŰ°í ±× ±â´ÉÀ» ³ªÅ¸³»µµ·Ï ÇÏ¿© Á¦2Â÷ ¶Ç´Â Á¦3Â÷ ¼ºÂ¡À» ¹ß´Þ½Ã۴µ¥, ƯÈ÷ Æ÷À¯·ù¿¡¼­ ¹ßÁ¤À» ÀÏÀ¸Å°°Ô ÇÏ´Â µ¥¼­ ¹ßÁ¤ È£¸£¸óÀ̶ó´Â À̸§ÀÌ ºÙ¾ú´Ù. ³­¼Ò À̿ܿ¡µµ ŹÝÀ» ºñ·ÔÇÏ¿© ºÎ½Å ÇÇÁúÀ̳ª Á¤¼Ò·ÎºÎÅÍ ¼Ò·® ºÐºñµÇ´Âµ¥ ¿¡½ºÆ®·ÐÀ̳ª ¿¡½ºÆ®¶óµð¿Ã ¹× ÀÎü¿¡¼­ º¼ ¼ö ÀÖ´Â ¿¡½ºÆ®¸®¿Ã µî 3Á¾·ùÀÇ ½ºÅ×·ÎÀ̵尡 ¾Ë·ÁÁ® ÀÖ´Ù. È­ÇÐÀûÀ¸·Î ¾ÈÁ¤µÇ¾î ÀÖÀ¸¸ç Àڱà ¹ßÀ°, ³»¸· Áõ½Ä, Á¥»ù ¹ßÀ°, ±ÔÄ¢Àû ¿ù°æ, Á¦2Â÷ ¼ºÂ¡ µîÀ» ÃËÁøÇÑ´Ù. ÀÌ È£¸£¸óÀÇ ºÐºñ´Â ³úÇϼöü Àü¿±¿¡¼­ ºÐºñµÇ´Â ¿©Æ÷ ÀÚ±Ø È£¸£¸ó
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
inhibitory fibres Nerve fibre's that inhibit the activity of the nerve cells with which they have synaptic connections, or of the effector tissue (smooth muscle, heart muscle, glands) in which they terminate.
(05 Mar 2000)
inhibitory junction potential Hyperpolarization of smooth muscle produced by stimulation of inhibitory nerves.
(05 Mar 2000)
inhibitory-motor <physiology> A term applied to certain nerve centers which govern or restrain subsidiary centers, from which motor impressions issue.
Source: Websters Dictionary
(01 Mar 1998)
inhibitory nerve <anatomy, nerve> A nerve conveying impulses that diminish functional activity in a part.
(05 Mar 2000)
inhibitory postsynaptic potential The change in potential produced in the membrane of the next neuron when an impulse which has an inhibitory influence arrives at the synapse; it is a local change in the direction of hyperpolarization; the frequency of discharge of a given neuron is determined by the extent to which impulses that lead to excitatory postsynaptic potential's predominate over those that cause inhibitory postsynaptic potential's.
(05 Mar 2000)
inhibitory synapse A synapse in which an action potential in the presynaptic cell reduces the probability of an action potential occurring in the postsynaptic cell. The most common inhibitory neurotransmitter is GABA, this opens channels in the postsynaptic cell which tend to stabilise its resting potential, thus rendering it less likely to fire.
See: excitatory synapse, presynaptic inhibition, postsynaptic inhibition.
(18 Nov 1997)
Leukaemia inhibitory factor <growth factor> Polypeptide growth factor or cytokine with wide range of activities. Regulates growth and differentiation of primordial germ cells and embryonic stem cells but has effects on peripheral neurons, osteoblasts, adipocytes and various cells of the myeloid lineage. Given to adult animals induces weight loss, behavioural disorders and bone abnormalities. Many of the effects of LIF in vitro can be mimicked by IL-6, oncostatin M and ciliary neurotrophic factor, all of which interact indirectly with gp130, a shared tranducer subunit.
(18 Nov 1997)
leukocyte migration-inhibitory factors Protein factor(s) released by sensitised lymphocytes (and possibly other cells) that inhibit the movement of leukocytes, especially polymorphonuclear cells, away from their site of release. Assays for these factors are used as tests for cellular immunity. Two of the common assays are the leukocyte migration capillary tube technique (lmct) and the leukocyte migration agarose technique (lmat).
(12 Dec 1998)
adipokinetic hormone An anterior pituitary hormone that causes mobilization of fat from adipose tissue.
Synonym: adipokinetic hormone.
(05 Mar 2000)
adrenal androgen-stimulating hormone A putative pituitary hormone that may be responsible for increased secretion of adrenal androgens at the time of puberty.
(05 Mar 2000)
adrenocorticotrophic hormone <endocrinology> A peptide hormone that is produced by the anterior pituitary gland. It stimulates the adrenal cortex to secrete glucocorticoid hormones, which help cells synthesise glucose, catabolize proteins, mobilizefree fatty acids and inhibit inflammation in allergic responses.
(10 May 1997)
adrenocorticotropic hormone The hormone of the anterior lobe of the hypophysis which governs the nutrition and growth of the adrenal cortex, stimulates it to functional activity, and also possesses extraadrenal adipokinetic activity; it is a polypeptide containing 39 amino acids, but exact structure varies from one species to another; sometimes prefixed by a to distinguish it from beta-corticotropin. The first thirteen amino acids at the N-terminal region are identical to alpha-melanotropin.
Synonym: adrenocorticotropin, adrenotropic hormone, adrenotropin, corticotropic hormone, corticotropin.
(05 Mar 2000)
adrenotropic hormone The hormone of the anterior lobe of the hypophysis which governs the nutrition and growth of the adrenal cortex, stimulates it to functional activity, and also possesses extraadrenal adipokinetic activity; it is a polypeptide containing 39 amino acids, but exact structure varies from one species to another; sometimes prefixed by a to distinguish it from beta-corticotropin. The first thirteen amino acids at the N-terminal region are identical to alpha-melanotropin.
Synonym: adrenocorticotropin, adrenotropic hormone, adrenotropin, corticotropic hormone, corticotropin.
(05 Mar 2000)
androgenic hormone <endocrinology> A male (masculinising) hormone. These medications (testosterone, methyltestosterone, fluoxymesterone, danazol) are used to treat androgen deficiency, delayed puberty in males and some forms of breast cancer.
(27 Sep 1997)
anterior pituitary-like hormone A glycoprotein with a carbohydrate fraction composed of d-galactose and hexosamine, extracted from the urine of pregnant women and produced by the placental trophoblastic cells; its most important role appears to be stimulation, during the first trimester, of ovarian secretion of the oestrogen and progesterone required for the integrity of conceptus; it appears to play no significant role in the last two trimesters of pregnancy, as the oestrogen and progesterone are then formed by the placenta.
Synonym: anterior pituitary-like hormone, choriogonadotropin, chorionic gonadotropic hormone, chorionic gonadotrophic hormone, placenta gonadotropin, placentagonadotropin.
(05 Mar 2000)
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 2
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 2
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 2
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 2
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 2
ÅëÇÕ°Ë»ö ¿Ï·á